Ronovo Surgical
PrivateLast Round
Series D
Sep 5, 2025
Est. Valuation
$1.3B
Total Funding Raised
$171.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ronovo Surgical operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series D round in September 2025.
Ronovo Surgical is a medical technology company that develops the Carina™ modular robotic-assisted surgery platform for soft tissue procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ronovo Surgical Comparables
Compare Ronovo Surgical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cornerstone Robotics | 88% | |
| Edge Medical Robotics | 86% | |
| Tuodao Medical Technology Co., Ltd. | 85% |
For institutional investors. Book with your work email.
Ronovo Surgical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 5, 2025 | ||||
| Series B | Jun 20, 2024 | ||||
| Series B Extension | Aug 30, 2023 | ||||
| Series A Extension | Feb 1, 2023 | ||||
| VC Round | Dec 1, 2022 | ||||
Seed | Apr 23, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ronovo Surgical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longriver Investment Partners | Series B Extension |
| YuanBio Venture Capital | Series B Extension |
| 渶策资本 | Series D, Series B |
| Granite Asia | Series D, Series C |
| NRL Capital | Series B Extension |
| MPC | VC Round, Series B Extension, Series A Extension, Series A |
| LongRiver Investments | Series B, Series B Extension, VC Round, Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 507% MoM, reaching 2K.
- Aug 3, 2026
Open roles increased to 383, 833% of headcount.
For institutional investors. Book with your work email.
Ronovo Surgical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ronovo Surgical's valuation, stock price, and market status.
Is Ronovo Surgical a public or private company?
Ronovo Surgical is a private company.
What is the current stock price of Ronovo Surgical?
Ronovo Surgical is a private company, so its shares have no public market price. Caplight tracks Ronovo Surgical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ronovo Surgical worth (valuation)?
Ronovo Surgical's valuation is estimated at $1.3B based on funding round data.
Can I buy Ronovo Surgical stock?
Ronovo Surgical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ronovo Surgical's last funding round?
Ronovo Surgical's most recent funding round was Series D on September 5, 2025.
Who are the main investors in Ronovo Surgical?
Key investors in Ronovo Surgical include 渶策资本, Granite Asia, NRL Capital, MPC, LongRiver Investments.
Will Ronovo Surgical IPO soon?
No public IPO plans have been announced for Ronovo Surgical.
How can I track Ronovo Surgical secondary market activity?
Caplight tracks bids, offers, and trades in Ronovo Surgical's shares on secondary markets.